The Coca-Cola Company is a global leader in the beverage industry, renowned for its portfolio of soft drinks, juices, teas, coffees, and water products. Headquartered in Atlanta, Georgia, the company focuses on manufacturing, marketing, and distributing non-alcoholic beverages, with its flagship product being the iconic Coca-Cola soft drink. With a commitment to sustainability and innovation, Coca-Cola continually expands its offerings to meet consumer preferences, emphasizing healthier options and environmentally friendly practices. The company operates in numerous markets worldwide, leveraging its extensive distribution network to ensure that its products are accessible to a diverse range of consumers. Read More
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the beverages, alcohol, and tobacco stocks, including Coca-Cola (NYSE:KO) and its peers.
Shares of breakfast restaurant chain First Watch Restaurant Group (NASDAQ:FWRG)
jumped 7.7% in the morning session after TD Cowen upgraded the stock's rating from Hold to Buy and assigned a price target of $22, which implied a potential 20% upside. The firm anticipated improvements in same-store sales due to "more effective" marketing. This upgrade suggested that TD Cowen felt there was a decent possibility of an upward surprise to FWRG's growth projection, which could translate to improved investor sentiment.
Shares of fashion conglomerate PVH (NYSE:PVH)
jumped 18.7% in the morning session after the company reported impressive fourth quarter 2024 results, with sales and earnings exceeding Wall Street's expectations. In North America, sales remained steady, supported by the benefit of earlier wholesale shipments. Meanwhile, European sales declined as planned, reflecting the company's deliberate strategy to prioritize quality over volume.
Shares of energy drink company Celsius (NASDAQ:CELH)
jumped 8.9% in the afternoon session after Truist analysts upgraded the stock's rating from Hold to Buy and raised the price target from $35 to $45. The analysts added, "In our opinion, the market is already looking past the hiccups of the legacy business in 2024 and the brand's slowdown in 1Q25."
Value stocks are outperforming flashy growth rivals due to market uncertainty, making value-based ETFs a good bet for steady income and diversification.
Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT)
jumped 94.9% in the afternoon session after the company announced that its Phase 3 trial (ROSELLA) met its goal of improving progression-free survival and overall survival in treating resistant ovarian cancer with a new therapy (a combination of Relacorilant and Nab-paclitaxel).
Shares of cyber security company SentinelOne (NYSE:S)
fell 6.3% in the morning session after anxiety and uncertainty rattled markets as the major stock indices pulled back in the morning session amid concerns about "reciprocal tariffs" to be announced later in the week. The planned tariffs, scheduled for April 2, 2025 (dubbed Liberation Day), were targeted at all countries where the United States had a trade deficit.
Shares of biotech company Sarepta Therapeutics (NASDAQ:SRPT)
fell 10.8% in the afternoon session after RBC analyst Brian Abrahams downgraded the stock from a Buy to a Hold rating and slashed the price target by nearly 50% to $87. The downgrade was driven by weaker-than-anticipated feedback from physicians regarding ELEVIDYS, suggesting that market reception for the treatment had fallen short. Notably, ELEVIDYS had been a big piece of Sarepta's growth story as it contributed more than 50% of sales in the Q4'2024 quarter.
The Dow Jones is made up of 30 of the most established and influential companies in the market.
But even blue-chip stocks can struggle - some are dealing with slowing growth, outdated business models, or increasing competition.
Outdoor specialty retailer Sportsman's Warehouse (NASDAQ:SPWH) will be announcing earnings results tomorrow after the bell. Here’s what investors should know.
Knowing which stocks to hold for the long term and which to sell before they drag down your portfolio is a challenge every investor faces at least once in their journey.
